The EOLIA randomised controlled trial, 1 which was published in 2018, did not show a
significant difference in its prespecified primary endpoint of 60-day mortality between the …

Respiratory extracorporeal membrane oxygenation (ECMO) in England and Scotland is
provided by a multicentre service, which has been commissioned and regulated by the …

It might seem counterintuitive to reduce the provision of ECMO at precisely the time when
demand increases, yet it could be deemed necessary. In this Comment, we argue that a …

Over the past 30 years, extracorporeal membrane oxygenation (ECMO), in both venoarterial
and venovenous configuration, has become the standard of care for neonates with severe …

Extracorporeal membrane oxygenation (ECMO) can serve as life-saving rescue therapy for
refractory respiratory failure in the setting of acute respiratory distress syndrome, such as …

Multiple mechanisms of dysregulation in the pulmonary perfusion exist in COVID-19: the
abolition of hypoxic pulmonary vasoconstriction, causing an increase in venous admixture; …

COVID-19 has ravished the world, with secondary consequences that are not yet possible to
estimate. WHO and the European Extracorporeal Life Support Organization (ELSO) …

WHO interim guidelines recommend offering extracorporeal membrane oxygenation
(ECMO) to eligible patients with acute respiratory distress syndrome (ARDS) related to …

Background Severe acute respiratory failure in adults causes high mortality despite
improvements in ventilation techniques and other treatments (eg, steroids, prone …

The role of extracorporeal membrane oxygenation (ECMO) in supporting refractory
respiratory failure in adults continues to evolve. Interest in ECMO surged after reports of …